| Hicham Ismail, MD | |
|
3623 Latrobe Dr Ste 216, Charlotte, NC 28211 | |
| (704) 384-3646 | |
| Not Available |
| Full Name | Hicham Ismail |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 10 Years |
| Location | 3623 Latrobe Dr Ste 216, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376961342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 35.128131 (Ohio) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 2019-01950 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
| Novant Health Rowan Medical Center | Salisbury, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mecklenburg Radiology Associates Pa | 6800789587 | 77 |
| Mecklenburg Radiology Associates Pa | 6800789587 | 77 |
News Archive
Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
New American College of Radiology and Society of Breast Imaging breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Entity Name | Columbus Radiology Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669408159 PECOS PAC ID: 6507754983 Enrollment ID: O20040308000742 |
News Archive
Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
New American College of Radiology and Society of Breast Imaging breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Entity Name | Mecklenburg Radiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295790657 PECOS PAC ID: 6800789587 Enrollment ID: O20191108001040 |
News Archive
Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
New American College of Radiology and Society of Breast Imaging breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hicham Ismail, MD Po Box 221249, Charlotte, NC 28222-1249 Ph: (704) 332-1291 | Hicham Ismail, MD 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Ph: (704) 384-3646 |
News Archive
Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
New American College of Radiology and Society of Breast Imaging breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
Whitney Feltus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 980-208-1704 Fax: 704-926-1832 | |
Edward Barnwell Black, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1705 East Blvd, Charlotte, NC 28203 Phone: 704-909-5960 Fax: 704-770-0501 | |
Thaddeus Drexel Houston, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1701 East Blvd, Charlotte, NC 28203 Phone: 704-334-7800 Fax: 704-414-7512 | |
Matthew James Locker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 704-332-1291 Fax: 704-926-1832 | |
Kelli A. Reardon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Queens Rd, Charlotte, NC 28204 Phone: 434-982-0777 Fax: 434-982-0792 | |
Mr. Andrew Joseph Bojanowski, PA-C Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 704-332-1291 | |
Dr. John William Black, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr, Suite 216, Charlotte, NC 28211 Phone: 704-332-1291 Fax: 704-332-5206 |